Arya Health
0%
est. 2Y upside i
Arya Health builds AI-powered digital agents that eliminate the administrative burden in post-acute care-so caregivers and coordinators can focus on patients, not processes. Purpose-built for home health, home care, and hospice, Arya integrates with leading EMRs to automate scheduling, compliance, onboarding, and more.
Rank
#2827
Sector
Healthcare Technology
Est. Liquidity
~5Y
Data Quality
Data: LowEquity upside cannot be reliably estimated due to missing revenue and valuation data.
Last updated: July 3, 2026
Valuation unknown; typical Series A bull case assumes 3-5x revenue multiple, but revenue data missing. High TAM and AI adoption could drive growth.
Without revenue or growth data, base case upside cannot be quantified. Company is early-stage with high incumbent threat.
Preference stack of $25M overhang could wipe out common equity if exit < $25M. Bear scenario assumes failure to scale or acquisition at low multiple.
Preference Stack Risk
highFunding Intensity
3570%$25M in preferred stock overhang against an unknown valuation; common equity at risk if exit below $25M.
Dilution Risk
highLikely multiple future rounds due to early stage; typical Series A dilution ~20% per round.
Secondary Liquidity
noneNo secondary market indicated; no recent secondary transactions.
Questions to Ask at the Interview
Strategic questions based on Arya Health's data — designed to show you've done your homework.
- 1
“How does your AI agent handle interoperability with legacy EMR systems?”
- 2
“What is your current ARR and growth rate?”
- 3
“What is the expected timeline to next funding round or liquidity event?”
Community
Valuation Sentiment
Our model estimates 0% upside. What do you think?
Anonymous. Do not share material non-public information.
Community Discussion
Comments are reviewed before they appear publicly.
Loading comments...
Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.